Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Bone Biologics Corp. (BBLG) had Return on Tangible Equity of -19.71% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-0.77M |
|
-- |
|
-- |
|
$0.81M |
|
$-0.81M |
|
$0.03M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.81M |
|
$-0.81M |
|
1.80M |
|
1.80M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$4.44M |
|
-- |
|
-- |
|
$4.44M |
|
$0.51M |
|
-- |
|
-- |
|
$0.51M |
|
$3.92M |
|
$3.92M |
|
$3.92M |
|
1.81M |
|
| Cash Flow Statement Financials | |
$-1.32M |
|
-- |
|
$0.02M |
|
$5.33M |
|
$4.03M |
|
$-1.30M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.71% |
|
|
Return on Tangible Equity |
-19.71% |
-17.44% |
|
-19.71% |
|
$2.17 |
|
$-0.74 |
|
$-0.74 |
|